The increasing use of CT scanning across all clinical indications has led to an exponential rise in the detection of incidental pulmonary nodules — small, focal opacities in the lung parenchyma measuring up to 30 mm in diameter. Studies estimate that CT lung nodules are present in 20–50% of all chest CT examinations in adults, depending on smoking history and population studied. The overwhelming majority of these nodules are benign (post-infectious, intrapulmonary lymph nodes, hamartomas), but a small but critically important minority represent early-stage lung cancer — where CT-guided detection offers a genuine opportunity for curative treatment.

Classifying Lung Nodules: The Radiologist's Framework

Lung nodules are classified by several key characteristics that inform risk stratification:

  • Density: Solid (completely opaque, obscures lung parenchyma), part-solid (mixed solid and ground-glass components), or pure ground-glass opacity (GGO, hazy increased attenuation without obscuring vessels)
  • Size: Measured in the axial plane as the average of the longest diameter and the perpendicular diameter. Size is the most important predictor of malignancy risk for solid nodules
  • Morphology: Round vs. irregular; smooth vs. lobulated vs. spiculated margins. Spiculation and lobulation are high-risk features suggesting invasive growth
  • Number: Solitary vs. multiple. Multiple nodules most commonly reflect metastatic disease or disseminated infection (e.g., miliary TB, fungal infection)
  • Location: Upper lobe location is independently associated with higher malignancy risk

The Fleischner Society Guidelines for Incidental Nodules

The Fleischner Society guidelines (2017) are the internationally accepted framework for managing incidentally detected lung nodules in adults over 35 years without a prior history of lung cancer. Recommendations vary based on nodule size, density (solid vs. subsolid), and patient risk profile (low risk: never/light smoker with no other risk factors vs. high risk: significant smoking history, occupational exposure, or family history of lung cancer):

  • Solid nodules less than 6 mm: No routine follow-up in low-risk patients; optional 12-month CT in high-risk patients
  • Solid nodules 6–8 mm: CT follow-up at 6–12 months, then 18–24 months if no change
  • Solid nodules greater than 8 mm: CT at 3 months, PET-CT, or tissue sampling depending on clinical context
  • Pure GGO nodules less than 6 mm: No follow-up in low-risk patients
  • Pure GGO nodules 6 mm or greater: Follow-up CT at 6–12 months to confirm persistence, then annually for 5 years if unchanged
  • Part-solid nodules 6 mm or greater: CT at 3–6 months to confirm persistence, then annually for 5 years if unchanged; solid component growth warrants PET/CT or biopsy

Lung-RADS: CT Lung Cancer Screening

The Lung CT Screening Reporting and Data System (Lung-RADS) was developed by the American College of Radiology specifically for low-dose CT (LDCT) lung cancer screening in high-risk individuals (age 50–80, 20+ pack-year smoking history). Lung-RADS assigns categories 1–4 based on nodule burden and individual nodule characteristics, each linked to a specific recommended management action. Category 4B and 4X nodules require further workup with PET-CT, CT-guided biopsy, or bronchoscopy. LDCT screening has been shown in the NLST and NELSON trials to reduce lung cancer mortality by 20–26% in high-risk populations.

High-Risk Morphological Features

Certain CT morphological features are strongly associated with malignancy and should prompt expedited evaluation regardless of nodule size: Spiculated margins — irregular star-shaped border reflecting tumor invasion into adjacent lung — are the single most worrying feature with a malignancy probability exceeding 90% in some series. Pleural tethering (linear strand from nodule to pleural surface), vascular convergence (vessels appearing to feed into the nodule), and the air bronchogram sign within a nodule (particularly in adenocarcinoma) are additional features requiring close attention and often tissue sampling.